SESSIONS OVERVIEW
HALL A
(CLINICAL COMMUNICATIONS)
9:00-10.00 SESSION 5A:FROM CLINICAL CONCEPT TO CLINICAL APPLICATION
Chairs:Botros Rizk (USA), Samir Hamamah (FR)
Jose Buratini (IT) - Messages From the Follicle Towards A New Model of Ovarian Stimulation
To Be Announced
10:30-13:00 SESSION 6A:RECURRENT PREGNANCY LOSS
Chair:Chadi Yazbeck
Wu Jinxiang (IT) - Recurrent Pregnancy Loss and Maternal Anxiety Affects Endometrial Receptivity and Embryo
Implantation Through Monoamine System Signaling
Melissa Morals (CR) - Fertility Preservation Medical and Social Reasons
Marie Carbonnel (FR) - Endometrial Immune Dysfunction in Recurrent Pregnancy Loss
Arsene Mekinian (FR) - When to Consider Immune Origin of Recurrent Miscariages and Which Immunomodulatory Perspectives.
To Be Announced
13:00-14:00 SYMPOSIUM/LUNCH
14:00-15:30 SESSION 7A:UTERINE TRANSPLANTATION-ACHIEVEMENTS AND PROSPECTS
Chair:Philippe Merviel*(FR)
Jean Marc Ayoubi (FR) - Uterus Transplantation Issue: What Future?
Francois Olivennes* (FR) - Surrogacy
Margot Lherbet* (FR) - Renouncement
16:00-17:00 SESSION 8A:UPDATE ON SURGICAL TREATMENTS
Chair:Hervé Fernandez*
Marie Carbonnel (FR) - Surgical Procedures for Infertility Management: Myomectomy: What Results forUpper Approach?
Guillaume Legendre* (FR) - Is it time to create expertise centers?
HALL B
(CLINICAL COMMUNICATIONS)
​9:00-13:00 SESSION 5B:FERTILITY PRESERVATION MEDICAL AND SOCIAL REASONS
Chairs:Marie Carbonel*
Marine Poulain* and Meli Morales (Distance) - Social Reasons to Consider Fertility Preservation
Kamila Kolanska (FR) - Medical Reasons to Consider Fertility Preservation
Giuseppe Gullo (IT) - Fertility Preservation in the Denatality ERA
Stephan Khmil (UK) - Soldiers’ Fertility Preservation during Ukrainian War
Rémi Béranger (FR) - The Later Impact of Toxic Products on Infertility
13:00-14:00 SYMPOSIUM/LUNCH​
14:00-15:30 SESSION 6B:PROSPECTS OF EMBRYOSCOPY
Chair:Nadia Kazdar* (FR)
Sciorio Romualdo (CH) - Optimize Embryo Culture to Increase Blastocyst Stage Single Transfer
J Paulo Moreira (UK) - Exposure of Women Undergoing In-Vitro Fertilization to Per-and Polyfluoroalkyl Substances: Evidence of n Negative Effects on Fertilization and High-Quality Embryos
15:30-16:00 SESSION 7B:PATIENT SECURITY
Chair:
Bouchra El Amiri (MAR) - Exploring Endogenous and Exogenous Factors for Successful Artificial Insemination in Sheep : A Global Overview
Nadia Kazdar (FR) - Interest of identification vigilance in IVF lab
16:30-17:30 SESSION 8B:PREIMPLANTATION EPIGENETIC AND GENETIC DIAGNOSIS: BENEFITS AND CONCERS
Chairs:Patricia Fauque*, Julie Barberet*
Sciorio Romualdo (CH) - Epigenetics & ART: A Two-Decade Review
To Be Announced
17:30-18:00 SESSION 9B:FREE COMMUNICATION
Chair:Marine Poulain*
Agnès Arbat (ES) - Efficacy Results From the Phase II Randomized Clinical Trial: OXO-001 in Infertile Women
Undergoing Egg Donation IVF/ICSI
J. Adeghe (UK) - Obstetric Problem on Women with Infertility with Special Reference of ASHERMAN
Jiang Dan (UK) - The Role and Significance of Traditional Chinese Medicine (TCM) in Assisted Reproductive
Technology (ART)
Ali Halassa Sofiane (ALGR) - Tuberculosis of the Female Genital Tract Discovered During Workups for Infertility
Kidest Gebeyehu (ET) - Tuberculosis of the Female Genital Tract: Histopathologic Patterns and Implications for
Infertility Management​
08:00-08:30 REGISTRATION AND WELCOME
09:00-10:00 SESSION 1C:THE FIVE STEPS TO CREATE AN IVF CENTER
10:00-10:30 COFFEE BREAK
10:30-11:30 SESSION 2C:DEVELOPMENT OF AN IVF CENTER - ORGANIC GROWTH
11:30-12:30 SESSION 3C:DEVELOPMENT OF AN IVF CENTER - EXTERNAL GROWTH
13:00-14:00 LUNCH AND SYMPOSIUMS
14:00-15:00 SESSION 4C:FINANCIAL ASPECTS OF AN IVF CENTER
15:00-16:00 SESSION 5C:VALUE OF AN IVF CENTER
16:00-17:00 SESSION 6C:TRANSMITTING PERENNATION OF AN IVF CENTER
17:00-17:30 CONCLUSIONS